Literature DB >> 10327163

Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression.

L Caberlotto1, P Jimenez, D H Overstreet, Y L Hurd, A A Mathé, K Fuxe.   

Abstract

Previously, we observed specific alterations of neuropeptide Y (NPY) and Y1 receptor mRNA expression in discrete regions of the Flinders Sensitive Line rats (FSL), an animal model of depression. In order to clarify the correlation between mRNA expression and protein content, radioimmunoassay and receptor autoradiography were currently performed. In the FSL rats, NPY-like immunoreactivity (NPY-LI) was decreased in the hippocampal CA region, while Y1 binding sites were increased; NPY-LI was increased in the arcuate nucleus. Fluoxetine treatment elevated NPY-LI in the arcuate and anterior cingulate cortex and increased Y1 binding sites in the medial amygdala and occipital cortex in both strains. No differences were found regarding the Y2 binding sites. The results demonstrate a good correlation between NPY peptide and mRNA expression, and sustain the possible involvement of NPY and Y1 receptors in depression.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10327163     DOI: 10.1016/s0304-3940(99)00234-7

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  13 in total

Review 1.  Neuropeptide Y and posttraumatic stress disorder.

Authors:  R Sah; T D Geracioti
Journal:  Mol Psychiatry       Date:  2012-07-17       Impact factor: 15.992

2.  Fear induced neuronal alterations in a genetic model of depression: an fMRI study on awake animals.

Authors:  Wei Huang; Meghan E Heffernan; Zhixin Li; Nanyin Zhang; David H Overstreet; Jean A King
Journal:  Neurosci Lett       Date:  2010-12-04       Impact factor: 3.046

Review 3.  What doesn't kill you makes you stranger: Dipeptidyl peptidase-4 (CD26) proteolysis differentially modulates the activity of many peptide hormones and cytokines generating novel cryptic bioactive ligands.

Authors:  Ahmed M Elmansi; Mohamed E Awad; Nada H Eisa; Dmitry Kondrikov; Khaled A Hussein; Alexandra Aguilar-Pérez; Samuel Herberg; Sudharsan Periyasamy-Thandavan; Sadanand Fulzele; Mark W Hamrick; Meghan E McGee-Lawrence; Carlos M Isales; Brian F Volkman; William D Hill
Journal:  Pharmacol Ther       Date:  2019-02-10       Impact factor: 12.310

4.  Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study.

Authors:  Anuradha Sharma; Xinguo Ren; Hui Zhang; Ghanshyam N Pandey
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2021-08-17       Impact factor: 5.067

5.  Affective status in relation to impulsive, motor and motivational symptoms: personality, development and physical exercise.

Authors:  Tomas Palomo; Richard J Beninger; Richard M Kostrzewa; Trevor Archer
Journal:  Neurotox Res       Date:  2008-10       Impact factor: 3.911

6.  Allele-specific programming of Npy and epigenetic effects of physical activity in a genetic model of depression.

Authors:  P A Melas; A Lennartsson; H Vakifahmetoglu-Norberg; Y Wei; E Åberg; M Werme; M Rogdaki; M Mannervik; G Wegener; S Brené; A A Mathé; C Lavebratt
Journal:  Transl Psychiatry       Date:  2013-05-07       Impact factor: 6.222

7.  Targeting the Neuropeptide Y System in Stress-related Psychiatric Disorders.

Authors:  Nicole M Enman; Esther L Sabban; Paul McGonigle; Elisabeth J Van Bockstaele
Journal:  Neurobiol Stress       Date:  2015-01-01

8.  The Role of Neuropeptide Y mRNA Expression Level in Distinguishing Different Types of Depression.

Authors:  Yingying Yue; Haitang Jiang; Yingying Yin; Yuqun Zhang; Jinfeng Liang; Shenghua Li; Jun Wang; Jianxin Lu; Deqin Geng; Aiqin Wu; Yonggui Yuan
Journal:  Front Aging Neurosci       Date:  2016-12-27       Impact factor: 5.750

9.  Antidepressant-like activity of the neuropeptide Y Y5 receptor antagonist Lu AA33810: behavioral, molecular, and immunohistochemical evidence.

Authors:  Helena Domin; Bernadeta Szewczyk; Bartłomiej Pochwat; Monika Woźniak; Maria Śmiałowska
Journal:  Psychopharmacology (Berl)       Date:  2016-12-14       Impact factor: 4.530

Review 10.  Neuropeptide Y in Alcohol Addiction and Affective Disorders.

Authors:  Annika Thorsell; Aleksander A Mathé
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.